Malabsorption, CTCAE
|
phenotype |
|
Finding
|
175
|
|
0.100 |
None |
|
0 |
|
|
|
Decreased activity of NADPH oxidase
|
phenotype |
|
Finding
|
5
|
|
0.100 |
None |
|
0 |
|
|
|
Recurrent Staphylococcus aureus infections
|
phenotype |
|
Finding
|
11
|
1
|
0.100 |
None |
|
0 |
|
|
|
Recurrent Klebsiella infections
|
phenotype |
|
Finding
|
5
|
|
0.100 |
None |
|
0 |
|
|
|
Recurrent Serratia marcescens infections
|
phenotype |
|
Finding
|
4
|
|
0.100 |
None |
|
0 |
|
|
|
Cellulitis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Infections; Skin and Connective Tissue Diseases
|
Pathologic Function
|
38
|
1
|
0.100 |
None |
|
0 |
|
|
|
Malabsorption
|
phenotype |
Digestive System Diseases
|
Finding
|
175
|
3
|
0.100 |
None |
|
0 |
|
|
|
Recurrent Burkholderia cepacia infections
|
phenotype |
|
Finding
|
4
|
|
0.100 |
None |
|
0 |
|
|
|
Recurrent respiratory infections
|
phenotype |
Infections; Respiratory Tract Diseases
|
Finding
|
318
|
7
|
0.100 |
None |
|
0 |
1
|
|
|
Recurrent Aspergillus infections
|
phenotype |
|
Finding
|
5
|
|
0.100 |
None |
|
0 |
|
|
|
Absence of bactericidal oxidative respiratory burst in phagocytes
|
phenotype |
|
Finding
|
4
|
|
0.100 |
None |
|
0 |
|
|
|
Deficiency or absence of cytochrome b(-245)
|
phenotype |
|
Finding
|
2
|
|
0.100 |
None |
|
0 |
|
|
|
Recurrent bacterial skin infections
|
phenotype |
|
Finding
|
13
|
1
|
0.100 |
None |
|
0 |
|
|
|
Hypermelanotic macule
|
phenotype |
|
Finding
|
59
|
2
|
0.100 |
None |
|
0 |
|
|
|
Arteriopathic disease
|
group |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
101
|
14
|
0.010 |
None |
1.000 |
1 |
|
2000 |
2000 |
Peripheral arterial occlusive disease
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
35
|
3
|
0.010 |
None |
< 0.001 |
1 |
|
2000 |
2000 |
Eclampsia
|
disease |
Female Urogenital Diseases and Pregnancy Complications
|
Disease or Syndrome
|
241
|
38
|
0.010 |
None |
< 0.001 |
1 |
|
2002 |
2002 |
Alloxan Diabetes
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Experimental Model of Disease
|
112
|
|
0.300 |
None |
1.000 |
2 |
|
2002 |
2003 |
Streptozotocin Diabetes
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Experimental Model of Disease
|
112
|
|
0.300 |
None |
1.000 |
2 |
|
2002 |
2003 |
Myocardial Ischemia
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
756
|
103
|
0.010 |
None |
< 0.001 |
1 |
|
2003 |
2003 |
MYELODYSPLASTIC SYNDROME
|
group |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1033
|
95
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |
Cerebral Aneurysm
|
disease |
Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
65
|
3
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |
Hyperuricemia
|
disease |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
196
|
76
|
0.020 |
None |
1.000 |
2 |
|
2004 |
2004 |
Coronary Artery Vasospasm
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
30
|
9
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Reperfusion Injury
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Injury or Poisoning
|
300
|
|
0.200 |
None |
1.000 |
1 |
|
2004 |
2004 |